The twelfth edition of the annual international life sciences conference BioAsia 2015 is all set to kickstart from Feb 2-4 in Hyderabad.
Over 50 countries are expected to participate in the conference and more than 100 speakers (global industry leaders, researchers, policy makers, innovators, and investors) at 40 sessions will speak during the event whose theme is 'New era of life sciences - opportunities in transition'
The global life sciences industry is undergoing an unprecedented transformation. With cost containment measures by the government and moves to cut health expenditures across continents, the pressure on global drug industry to reap more from less is palpable.
BioAsia provides an opportunity to explore business partnerships between the industry and academia. It will cover contemporary developments in research and will assist in building technology capabilities for life sciences and medical sciences sector, said a statement released by the organisers.
Thailand will be the principal country partner and Britain an associate country partner, it said.
The topics for the sessions include "Drug discovery and India's innovation pipeline", "Digital health and healthcare IT", "Clinical research", "Supply chain and logistics", "Rapid diagnostics" and "Public health and Access".
Shakthi Nagappan, CEO, BioAsia said that the event has an extraordinary line up of global industry leaders and academic experts.
The event will witness BioAsia Healthcare Devthon, where engineers and designers develop prototypes to address key healthcare challenges.
BioAsia 2015 is being organised by the Federation of Asian Biotech Association [FABA], government of Telangana and the Pharmaceutical Export Promotion Council (Pharmexcil) with the support of the Indian government.